Outlook for the Down syndrome child

Timing of radiotherapy (RT) after radical prostatectomy (RP): long-term outcomes in the RADICALS-RT trial (NCT00541047).

Annals of oncology : official journal of the European Society for Medical Oncology·2024

The natural history of low-risk non-muscle-invasive bladder cancer: a collaborative multi-centre study.

International urology and nephrology·2022

Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2019

Adding abiraterone or docetaxel to long-term hormone therapy for prostate cancer: directly randomised data from the STAMPEDE multi-arm, multi-stage platform protocol.

Annals of oncology : official journal of the European Society for Medical Oncology·2018

The genetic basis of colorectal cancer in a population-based incident cohort with a high rate of familial disease.

Gut·2010

Surgical treatment of the neuroischemic foot.

The Journal of cardiovascular surgery·2009

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Healthcare professionals' perspectives and preferences regarding adolescent meningococcal disease vaccination in the United States.

Expert review of vaccines·2026

A Nationwide Review of the Utilization of Rapid Antigen Testing for Group A Streptococcus.

Cureus·2026

Homozygous familial hypercholesterolemia, experience with Evinacumab treatment in two Mexican pediatric patients: case report.

Frontiers in genetics·2026

Psychiatric and medical profiles of children receiving health protection measures in a tertiary care facility: A five-year analysis.

Dusunen adam : Bakirkoy Ruh ve Sinir Hastaliklari Hastanesi yayin organi·2026

Predictors of parental stress in families of children with neurodevelopmental disabilities.

Dusunen adam : Bakirkoy Ruh ve Sinir Hastaliklari Hastanesi yayin organi·2026

Venous malformation with localized intravascular coagulopathy in children treated with sclerotherapy and LWMH.

Frontiers in pediatrics·2026

Related Experiment Videos

Outlook for the Down syndrome child

Related Concept Videos

Timing of radiotherapy (RT) after radical prostatectomy (RP): long-term outcomes in the RADICALS-RT trial (NCT00541047).

The natural history of low-risk non-muscle-invasive bladder cancer: a collaborative multi-centre study.

Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial.

Adding abiraterone or docetaxel to long-term hormone therapy for prostate cancer: directly randomised data from the STAMPEDE multi-arm, multi-stage platform protocol.

The genetic basis of colorectal cancer in a population-based incident cohort with a high rate of familial disease.

Surgical treatment of the neuroischemic foot.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Healthcare professionals' perspectives and preferences regarding adolescent meningococcal disease vaccination in the United States.

A Nationwide Review of the Utilization of Rapid Antigen Testing for Group A Streptococcus.

Homozygous familial hypercholesterolemia, experience with Evinacumab treatment in two Mexican pediatric patients: case report.

Psychiatric and medical profiles of children receiving health protection measures in a tertiary care facility: A five-year analysis.

Predictors of parental stress in families of children with neurodevelopmental disabilities.

Venous malformation with localized intravascular coagulopathy in children treated with sclerotherapy and LWMH.

Related Experiment Videos

Outlook for the Down syndrome child

Related Concept Videos

Related Articles